Osteopontin is not required for the development of Th1 responses and viral immunity

被引:29
作者
Abel, B
Freigang, S
Bachmann, MF
Boschert, U
Kopt, M
机构
[1] Swiss Fed Inst Technol, Mol Biomed, CH-8952 Zurich, Schlieren, Switzerland
[2] Cytos Biotechnol AG, Zurich, Switzerland
[3] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland
[4] Serono Pharmaceut Res Inst, Dept Immunol, Geneva, Switzerland
关键词
D O I
10.4049/jimmunol.175.9.6006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Osteopontin (OPN) has been defined as a key cytokine promoting the release of IL-12 and hence inducing the development of protective cell-mediated immunity to viruses and intracellular pathogens. To further characterize the role of OPN in antiviral immunity, OPN-deficient (OPN-/-) mice were analyzed after infection with influenza virus and vaccinia virus. Surprisingly, we found that viral clearance, lung inflammation, and recruitment of effector T cells to the lung were unaffected in OPN-/- mice after influenza infection. Furthermore, effector status of T cells was normal as demonstrated by normal IFN-gamma production and CTL lytic activity. Moreover, activation and Th1 differentiation of naive TCR transgenic CD4(+) T cells by dendritic cells and cognate Ag was normal in the absence of OPN in vitro. Contrary to a previous report, we found that OPN-/- mice mounted a normal immune response to Listeria monocytogenes. In conclusion, OPN is dispensable for antiviral immune responses against influenza virus and vaccinia virus.
引用
收藏
页码:6006 / 6013
页数:8
相关论文
共 47 条
  • [1] Ablation of interleukin-12 exacerbates lyme arthritis in SCID mice
    Anguita, J
    Samanta, S
    Barthold, SW
    Fikrig, E
    [J]. INFECTION AND IMMUNITY, 1997, 65 (10) : 4334 - 4336
  • [2] Effect of anti-interleukin 12 treatment on murine lyme borreliosis
    Anguita, J
    Persing, DH
    Rincon, M
    Barthold, SW
    Fikrig, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (04) : 1028 - 1034
  • [3] Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity
    Ashkar, S
    Weber, GF
    Panoutsakopoulou, V
    Sanchirico, ME
    Jansson, M
    Zawaideh, S
    Rittling, SR
    Denhardt, DT
    Glimcher, MJ
    Cantor, H
    [J]. SCIENCE, 2000, 287 (5454) : 860 - 864
  • [4] INDUCTION OF PROTECTIVE CYTOTOXIC T-CELLS WITH VIRAL-PROTEINS
    BACHMANN, MF
    KUNDIG, TM
    FREER, G
    LI, Y
    KANG, CY
    BISHOP, DH
    HENGARTNER, H
    ZINKERNAGEL, RM
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (09) : 2228 - 2236
  • [5] Influenza virus: a novel method to assess viral and neutralizing antibody titers in vitro
    Bachmann, MF
    Ecabert, B
    Kopf, M
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 225 (1-2) : 105 - 111
  • [6] Blom T, 2003, SCIENCE, V299
  • [7] Dual role of interleukin-10 in murine lyme disease: Regulation of arthritis severity and host defense
    Brown, JP
    Zachary, JF
    Teuscher, C
    Weis, JJ
    Wooten, RM
    [J]. INFECTION AND IMMUNITY, 1999, 67 (10) : 5142 - 5150
  • [8] Osteopontin polymorphisms and disease course in multiple sclerosis
    Caillier, S
    Barcellos, LF
    Baranzini, SE
    Swerdlin, A
    Lincoln, RR
    Steinman, L
    Martin, E
    Haines, JL
    Pericak-Vance, M
    Hauser, SL
    Oksenberg, JR
    [J]. GENES AND IMMUNITY, 2003, 4 (04) : 312 - 315
  • [9] The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
    Chabas, D
    Baranzini, SE
    Mitchell, D
    Bernard, CCA
    Rittling, SR
    Denhardt, DT
    Sobel, RA
    Lock, C
    Karpuj, M
    Pedotti, R
    Heller, R
    Oksenberg, JR
    Steinman, L
    [J]. SCIENCE, 2001, 294 (5547) : 1731 - 1735
  • [10] Osteopontin gene haplotypes correlate with multiple sclerosis development and progression
    Chiocchetti, A
    Comi, C
    Indelicato, M
    Castelli, L
    Mesturini, R
    Bensi, T
    Mazzarino, MC
    Giordano, M
    D'Alfonso, S
    Momigliano-Richiardi, P
    Liguori, M
    Zorzon, M
    Amoroso, A
    Trojano, M
    Monaco, F
    Leone, M
    Magnani, C
    Dianzani, U
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2005, 163 (1-2) : 172 - 178